Guardian Pharmacy Services
GRDN
171 hedge funds and large institutions have $1.07B invested in Guardian Pharmacy Services in 2026 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 52 increasing their positions, 42 reducing their positions, and 14 closing their positions.
321% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 14
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
78% more capital invested
Capital invested by funds: $600M → $1.07B (+$466M)
33% more funds holding
Funds holding: 129 → 171 (+42)
24% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 42
23.1% more ownership
Funds ownership: 55% → 78.1% (+23%)
17% less call options, than puts
Call options by funds: $209K | Put options by funds: $252K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$77M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$33.6M |
| 3 |
Jennison Associates
New York
|
+$23.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$21M |
| 5 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$20.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
-$13M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$12.3M |
| 3 |
Millennium Management
New York
|
-$4.59M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.43M |
| 5 |
RA
Royce & Associates
New York
|
-$3.24M |
GRDN Hedge Fund Activity: Q1 2026 in Review
171 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Guardian Pharmacy Services (GRDN) for Q1 2026, worth a combined $1.07B — up 78% from $600M a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new GRDN positions and 14 closed out — a net gain of 45 holders — while 52 added to existing stakes and 42 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $77M. The largest seller was Silvercrest Asset Management, cutting an estimated $13M.
- 171 institutional investors held Guardian Pharmacy Services (GRDN) as of Q1 2026, up from 129 in Q4 2025.
- Funds reported $1.07B of Guardian Pharmacy Services stock for Q1 2026, up 78% quarter-over-quarter.
- 59 funds opened new Guardian Pharmacy Services positions in Q1 2026 and 14 closed out, a net change of +45 holders.
- The largest Guardian Pharmacy Services buyer in Q1 2026 was Fidelity Investments, an estimated $77M added.
- The largest Guardian Pharmacy Services seller in Q1 2026 was Silvercrest Asset Management, an estimated $13M sold.
Based on aggregated 13F filings for Q1 2026.